Logos Global Management LP
CIK
1792126
Location
San Francisco, CA
Portfolio Value
Mid
$2,002,915,078
Diversification
Diversified
Filing Date
Global Rank
#1,207
/ 8,622
▲ 196
· as of Mar 2026
Top Industry
Biotechnology
94.7%
3Y Alpha vs SPY
+13.4%
Period ended 4 months ago
Filed May 15, 2026 · 2mo
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Cloned portfolio
+131.0%
SPY
+67.9%
Annualised alpha
+13.3%
Max drawdown
−54.2%
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 92% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
63 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
9.7%
−5.7 pts
Top 5
34.3%
−4.9 pts
Top 10
50.7%
−2.3 pts
HHI
383
Diversified−113
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $2,002,915,078 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
23 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | +2,000,000 | 3,150,000 | $16,663,500 | |
| CNTA | Centessa Pharmaceuticals plc | +1,925,000 | 2,125,000 | $84,405,000 | |
| TERN | Terns Pharmaceuticals, Inc. | +1,250,000 | 2,000,000 | $105,440,000 | |
| TRVI | Trevi Therapeutics, Inc. | +850,000 | 2,400,000 | $28,632,000 | |
| ELVN | Enliven Therapeutics, Inc. | +700,000 | 1,040,000 | $40,768,000 | |
| VOR | Vor Biopharma Inc. | +650,000 | 750,000 | $13,380,000 | |
| IMCR | Immunocore Holdings plc | +650,000 | 1,500,000 | $45,225,000 | |
| TYRA | Tyra Biosciences, Inc. | +640,000 | 850,000 | $32,555,000 | |
| CYTK | Cytokinetics Inc | +575,000 | 875,000 | $57,671,250 | |
| ORIC | Oric Pharmaceuticals, Inc. | +500,000 | 950,000 | $12,036,500 | |
| CGON | CG Oncology, Inc. | +375,000 | 575,000 | $38,916,000 | |
| OCUL | Ocular Therapeutix, Inc | +350,000 | 3,850,000 | $32,609,500 | |
| MAZE | Maze Therapeutics, Inc. | +285,000 | 1,235,000 | $36,864,750 | |
| ABVX | Abivax S.A. | +275,000 | 675,000 | $75,161,250 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | +260,000 | 450,000 | $39,136,500 | |
| IMMX | Immix Biopharma, Inc. | +225,000 | 1,225,000 | $11,159,750 | |
| DYN | Dyne Therapeutics, Inc. | +150,000 | 1,400,000 | $25,382,000 | |
| RCUS | Arcus Biosciences, Inc. | +150,000 | 1,200,000 | $25,920,000 | |
| NAMS | NewAmsterdam Pharma Co N.V. | +150,000 | 600,000 | $19,206,000 | |
| CLDX | Celldex Therapeutics, Inc. | +100,000 | 450,000 | $14,274,000 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | +85,000 | 400,000 | $33,568,000 | |
| IRON | Disc Medicine, Inc. | +50,000 | 560,000 | $35,806,400 | |
| JBIO | Jade Biosciences, Inc. | +5,000 | 400,000 | $5,620,000 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
23 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ERAS | Erasca, Inc. | −1,850,000 | 11,150,000 | $180,407,000 | |
| TNGX | Tango Therapeutics, Inc. | −1,200,000 | 3,000,000 | $62,760,000 | |
| RVMD | Revolution Medicines, Inc. | −1,000,000 | 2,000,000 | $194,500,000 | |
| VSTM | Verastem, Inc. | −700,000 | 1,000,000 | $5,300,000 | |
| IBIO | iBio, Inc. | −700,000 | 1,300,000 | $2,470,000 | |
| DSGN | Design Therapeutics, Inc. | −550,000 | 1,950,000 | $20,748,000 | |
| PCVX | Vaxcyte, Inc. | −350,000 | 300,000 | $17,433,000 | |
| IMVT | Immunovant, Inc. | −300,000 | 1,075,000 | $26,703,000 | |
| LBRX | Lb Pharmaceuticals Inc | −285,000 | 915,000 | $22,563,900 | |
| MLTX | MoonLake Immunotherapeutics | −250,000 | 1,500,000 | $27,960,000 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | −250,000 | 700,000 | $9,730,000 | |
| IDYA | IDEAYA Biosciences, Inc. | −125,000 | 3,450,000 | $114,954,000 | |
| CBIO | Crescent Biopharma, Inc. | −117,500 | 482,500 | $8,863,525 | |
| GUTS | Fractyl Health, Inc. | −100,000 | 1,000,000 | $458,000 | |
| ACRS | Aclaris Therapeutics, Inc. | −100,000 | 500,000 | $1,875,000 | |
| GPCR | Structure Therapeutics Inc. | −100,000 | 500,000 | $24,100,000 | |
| ACAD | Acadia Pharmaceuticals Inc | −100,000 | 750,000 | $16,695,000 | |
| NERV | Minerva Neurosciences, Inc. | −96,000 | 3,215,000 | $19,370,375 | |
| PRAX | Praxis Precision Medicines, Inc. | −90,000 | 285,000 | $91,824,150 | |
| CRVS | Corvus Pharmaceuticals, Inc. | −50,000 | 450,000 | $6,583,500 | |
| SLNO | Soleno Therapeutics Inc | −50,000 | 250,000 | $8,370,000 | |
| PHVS | Pharvaris N.V. | −35,000 | 65,000 | $1,836,250 | |
| MIRM | Mirum Pharmaceuticals, Inc. | −25,000 | 200,000 | $18,476,000 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
11 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | 80,000 | $47,438,400 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 85,000 | $44,494,950 | |
| XENE | Xenon Pharmaceuticals Inc. | 450,000 | $26,167,500 | |
| AVTX | Avalo Therapeutics, Inc. | 1,300,000 | $19,409,000 | |
| ALKS | Alkermes plc. | 350,000 | $12,376,000 | |
| TENX | Tenax Therapeutics, Inc. | 625,000 | $9,993,750 | |
| AVBP | ArriVent BioPharma, Inc. | 350,000 | $8,074,500 | |
| RLAY | Relay Therapeutics, Inc. | 750,000 | $7,462,500 | |
| MGTX | MeiraGTx Holdings plc | 700,000 | $6,062,000 | |
| MANE | Veradermics, Inc | 25,000 | $1,578,750 | |
| FTH | Faeth Therapeutics, Inc. | 30,000 | $945,600 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
12 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals plc | 200,000 | $34,000,000 | |
| APLS | Apellis Pharmaceuticals, Inc. | 1,000,000 | $25,120,000 | |
| QURE | uniQure N.V. | 675,000 | $16,152,750 | |
| KNSA | Kiniksa Pharmaceuticals International, plc | 350,000 | $14,437,500 | |
| KYMR | Kymera Therapeutics, Inc. | 130,000 | $10,115,300 | |
| NRIX | Nurix Therapeutics, Inc. | 500,000 | $9,485,000 | |
| IMTX | Immatics N.V. | 850,000 | $8,925,000 | |
| ACLX | Arcellx, Inc. | 115,000 | $7,498,000 | |
| NGNE | Neurogene Inc. | 195,000 | $4,017,000 | |
| DAWN | Day One Biopharmaceuticals, Inc. | 300,000 | $2,796,000 | |
| MREO | Mereo BioPharma Group plc | 1,850,000 | $771,450 | |
| DBVT | DBV Technologies S.A. | 25,000 | $479,250 | |
| No positions match the current search. | ||||
63 tracked positions ·
$2,002,915,078 total
· as of Mar 31, 2026
Showing 1–50
of 63 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 2,000,000 | $194,500,000 | 9.71% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Reduced | 11,150,000 | $180,407,000 | 9.01% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Reduced | 3,450,000 | $114,954,000 | 5.74% | |
| TERN |
Terns Pharmaceuticals, Inc.
CALL
+ SHARES
Healthcare
|
Added | 2,000,000 | $105,440,000 | 5.26% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 285,000 | $91,824,150 | 4.58% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Added | 2,125,000 | $84,405,000 | 4.21% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 675,000 | $75,161,250 | 3.75% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Reduced | 3,000,000 | $62,760,000 | 3.13% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Added | 875,000 | $57,671,250 | 2.88% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
Held | 3,208,875 | $47,844,326 | 2.39% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
NEW | 80,000 | $47,438,400 | 2.37% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Added | 1,500,000 | $45,225,000 | 2.26% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
NEW | 85,000 | $44,494,950 | 2.22% | |
| ELVN |
Enliven Therapeutics, Inc.
CALL
+ SHARES
Healthcare
|
Added | 1,040,000 | $40,768,000 | 2.04% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 450,000 | $39,136,500 | 1.95% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Added | 575,000 | $38,916,000 | 1.94% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Added | 1,235,000 | $36,864,750 | 1.84% | |
| BIIB |
Biogen Inc.
Healthcare
|
Held | 200,000 | $36,666,000 | 1.83% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 560,000 | $35,806,400 | 1.79% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Added | 400,000 | $33,568,000 | 1.68% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
Added | 3,850,000 | $32,609,500 | 1.63% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Added | 850,000 | $32,555,000 | 1.63% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Added | 2,400,000 | $28,632,000 | 1.43% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Reduced | 1,500,000 | $27,960,000 | 1.40% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Reduced | 1,075,000 | $26,703,000 | 1.33% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
NEW | 450,000 | $26,167,500 | 1.31% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Added | 1,200,000 | $25,920,000 | 1.29% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 1,400,000 | $25,382,000 | 1.27% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Reduced | 500,000 | $24,100,000 | 1.20% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Reduced | 915,000 | $22,563,900 | 1.13% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
Reduced | 1,950,000 | $20,748,000 | 1.04% | |
| AVTX |
Avalo Therapeutics, Inc.
CALL
+ SHARES
Healthcare
|
NEW | 1,300,000 | $19,409,000 | 0.97% | |
| NERV |
Minerva Neurosciences, Inc.
Healthcare
|
Reduced | 3,215,000 | $19,370,375 | 0.97% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Added | 600,000 | $19,206,000 | 0.96% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Reduced | 200,000 | $18,476,000 | 0.92% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 300,000 | $17,433,000 | 0.87% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Reduced | 750,000 | $16,695,000 | 0.83% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Added | 3,150,000 | $16,663,500 | 0.83% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Added | 450,000 | $14,274,000 | 0.71% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
Held | 1,000,000 | $13,900,000 | 0.69% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
Added | 750,000 | $13,380,000 | 0.67% | |
| ALKS |
Alkermes plc.
Healthcare
|
NEW | 350,000 | $12,376,000 | 0.62% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Added | 950,000 | $12,036,500 | 0.60% | |
| IMMX |
Immix Biopharma, Inc.
Healthcare
|
Added | 1,225,000 | $11,159,750 | 0.56% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
NEW | 625,000 | $9,993,750 | 0.50% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Reduced | 700,000 | $9,730,000 | 0.49% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Reduced | 482,500 | $8,863,525 | 0.44% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Reduced | 250,000 | $8,370,000 | 0.42% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
NEW | 350,000 | $8,074,500 | 0.40% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
NEW | 750,000 | $7,462,500 | 0.37% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.